{"id":5977,"date":"2018-04-24T16:17:38","date_gmt":"2018-04-24T15:17:38","guid":{"rendered":"http:\/\/backup.altanalaw.com\/?p=5977"},"modified":"2018-11-23T10:26:15","modified_gmt":"2018-11-23T09:26:15","slug":"altana-conseille-les-actionnaires-de-biofides-et-a-r-c-pharma-dans-le-cadre-de-leur-cession-au-groupe-pharmalex","status":"publish","type":"post","link":"https:\/\/backup.altanalaw.com\/ja\/medias\/altana-conseille-les-actionnaires-de-biofides-et-a-r-c-pharma-dans-le-cadre-de-leur-cession-au-groupe-pharmalex","title":{"rendered":"Altana conseille les actionnaires de Biofides et A.R.C. Pharma dans le cadre de leur cession au groupe Pharmalex"},"content":{"rendered":"<p class=\"qtranxs-available-languages-message qtranxs-available-languages-message-ja\">\u7533\u3057\u8a33\u3042\u308a\u307e\u305b\u3093\u3001\u3053\u306e\u30b3\u30f3\u30c6\u30f3\u30c4\u306f\u305f\u3060\u4eca\u3000<a href=\"https:\/\/backup.altanalaw.com\/fr\/wp-json\/wp\/v2\/posts\/5977\" class=\"qtranxs-available-language-link qtranxs-available-language-link-fr\" title=\"Fran\u00e7ais\">Fran\u00e7ais<\/a>\u3068 <a href=\"https:\/\/backup.altanalaw.com\/en\/wp-json\/wp\/v2\/posts\/5977\" class=\"qtranxs-available-language-link qtranxs-available-language-link-en\" title=\"English\">English<\/a>\u3000\u306e\u307f\u3067\u3059\u3002 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language.<\/p><p>Paris, le 24 avril 2017<\/p>\n<p>Altana a conseill\u00e9 l\u2019ensemble des actionnaires des soci\u00e9t\u00e9s fran\u00e7aises Biofides et A.R.C. Pharma dans le cadre de la cession \u00e0 la soci\u00e9t\u00e9 Pharmalex France, filiale de la soci\u00e9t\u00e9 allemande Pharmalex GmbH, de la totalit\u00e9 du capital social et des droits de vote de Biofides et A.R.C. Pharma.<\/p>\n<p>Biofides est la soci\u00e9t\u00e9 m\u00e8re d\u2019A.R.C. Pharma, soci\u00e9t\u00e9 de conseil, d&#8217;information et d&#8217;assistance, sp\u00e9cialis\u00e9e en affaires r\u00e9glementaires pharmaceutiques depuis plus de 30 ans.<\/p>\n<p>Pharmalex est l\u2019un des leaders mondiaux en mati\u00e8re de conseil en affaires r\u00e9glementaires, en management de la qualit\u00e9, compliance et pharmacovigilance, ainsi qu\u2019en business d\u00e9veloppement pour l\u2019industrie pharmaceutique.<\/p>\n<p>Altana repr\u00e9sentait les vendeurs, \u00e0 savoir l\u2019actionnaire majoritaire et ses enfants d\u2019une part et les dirigeants op\u00e9rationnels actionnaires minoritaires d\u2019autre part.<\/p>\n<p>Pour l\u2019acqu\u00e9reur allemand, financ\u00e9 par le fonds Auctus Capital Partners AG et pr\u00e9sent sur tous les continents, cette op\u00e9ration s\u2019inscrit dans une strat\u00e9gie de build-up et d\u2019extension en termes de couverture g\u00e9ographique.<\/p>\n<p>Le management de l\u2019entit\u00e9 fran\u00e7aise sera confi\u00e9 \u00e0 Sophie Guillaume, qui repr\u00e9sentait d\u00e9j\u00e0 Pharmalex en France pr\u00e9alablement \u00e0 cette acquisition structurante pour le groupe.<\/p>\n<p>Au travers de cette op\u00e9ration, Altana d\u00e9montre une nouvelle fois l\u2019expertise du Cabinet dans le domaine des sciences de la vie et son fort positionnement sur les op\u00e9rations transfrontali\u00e8res.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter wp-image-5978\" src=\"http:\/\/backup.altanalaw.com\/wp-content\/uploads\/2018\/04\/JNS-VG-300x148.jpg\" alt=\"\" width=\"650\" height=\"321\" srcset=\"https:\/\/backup.altanalaw.com\/wp-content\/uploads\/2018\/04\/JNS-VG-300x148.jpg 300w, https:\/\/backup.altanalaw.com\/wp-content\/uploads\/2018\/04\/JNS-VG-600x296.jpg 600w, https:\/\/backup.altanalaw.com\/wp-content\/uploads\/2018\/04\/JNS-VG.jpg 699w\" sizes=\"(max-width: 650px) 100vw, 650px\" \/><\/p>\n<p><strong>Conseil des actionnaires de Biofides et A.R.C. Pharma<\/strong><\/p>\n<p>Altana,\u00a0avec Jean-Nicolas Soret (associ\u00e9) et Vincent Guilaine.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Conseil de Pharmalex France<\/strong><\/p>\n<p>R\u00f6dl, avec Anne-Sophie H\u00e9bras pour les aspects juridiques et Maximilian Egger pour les aspects financiers<\/p>","protected":false},"excerpt":{"rendered":"<p>\u7533\u3057\u8a33\u3042\u308a\u307e\u305b\u3093\u3001\u3053\u306e\u30b3\u30f3\u30c6\u30f3\u30c4\u306f\u305f\u3060\u4eca\u3000Fran\u00e7ais\u3068 English\u3000\u306e\u307f\u3067\u3059\u3002 For the sake of viewer convenience, the content is shown below in [&hellip;]<\/p>\n","protected":false},"author":14,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[125],"class_list":["post-5977","post","type-post","status-publish","format-standard","hentry","category-medias","tag-communique","expertise-droit-societes-fusions-acquisitions","avocat-jean-nicolas-soret"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title><\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"[:fr]Altana conseille les actionnaires de Biofides et A.R.C. Pharma dans le cadre de leur cession au groupe Pharmalex[:en]Altana advises the shareholders of Biofides et A.R.C. Pharma in their acquisition by the Pharmalex group.[:] - Altana\" \/>\n<meta property=\"og:description\" content=\"\u7533\u3057\u8a33\u3042\u308a\u307e\u305b\u3093\u3001\u3053\u306e\u30b3\u30f3\u30c6\u30f3\u30c4\u306f\u305f\u3060\u4eca\u3000Fran\u00e7ais\u3068 English\u3000\u306e\u307f\u3067\u3059\u3002 For the sake of viewer convenience, the content is shown below in [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/backup.altanalaw.com\/en\/medias\/altana-conseille-les-actionnaires-de-biofides-et-a-r-c-pharma-dans-le-cadre-de-leur-cession-au-groupe-pharmalex\" \/>\n<meta property=\"og:site_name\" content=\"Altana\" \/>\n<meta property=\"article:published_time\" content=\"2018-04-24T15:17:38+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-11-23T09:26:15+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/backup.altanalaw.com\/wp-content\/uploads\/2018\/04\/JNS-VG-300x148.jpg\" \/>\n<meta name=\"author\" content=\"Altana Communication\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Altana Communication\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"3\u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/backup.altanalaw.com\/en\/medias\/altana-conseille-les-actionnaires-de-biofides-et-a-r-c-pharma-dans-le-cadre-de-leur-cession-au-groupe-pharmalex\",\"url\":\"https:\/\/backup.altanalaw.com\/en\/medias\/altana-conseille-les-actionnaires-de-biofides-et-a-r-c-pharma-dans-le-cadre-de-leur-cession-au-groupe-pharmalex\",\"name\":\"[:fr]Altana conseille les actionnaires de Biofides et A.R.C. Pharma dans le cadre de leur cession au groupe Pharmalex[:en]Altana advises the shareholders of Biofides et A.R.C. Pharma in their acquisition by the Pharmalex group.[:] - Altana\",\"isPartOf\":{\"@id\":\"https:\/\/backup.altanalaw.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/backup.altanalaw.com\/en\/medias\/altana-conseille-les-actionnaires-de-biofides-et-a-r-c-pharma-dans-le-cadre-de-leur-cession-au-groupe-pharmalex#primaryimage\"},\"image\":{\"@id\":\"https:\/\/backup.altanalaw.com\/en\/medias\/altana-conseille-les-actionnaires-de-biofides-et-a-r-c-pharma-dans-le-cadre-de-leur-cession-au-groupe-pharmalex#primaryimage\"},\"thumbnailUrl\":\"http:\/\/backup.altanalaw.com\/wp-content\/uploads\/2018\/04\/JNS-VG-300x148.jpg\",\"datePublished\":\"2018-04-24T15:17:38+00:00\",\"dateModified\":\"2018-11-23T09:26:15+00:00\",\"author\":{\"@id\":\"https:\/\/backup.altanalaw.com\/#\/schema\/person\/4bdb47072f79b38f30b44735a4377af6\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/backup.altanalaw.com\/en\/medias\/altana-conseille-les-actionnaires-de-biofides-et-a-r-c-pharma-dans-le-cadre-de-leur-cession-au-groupe-pharmalex\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\/\/backup.altanalaw.com\/en\/medias\/altana-conseille-les-actionnaires-de-biofides-et-a-r-c-pharma-dans-le-cadre-de-leur-cession-au-groupe-pharmalex#primaryimage\",\"url\":\"http:\/\/backup.altanalaw.com\/wp-content\/uploads\/2018\/04\/JNS-VG-300x148.jpg\",\"contentUrl\":\"http:\/\/backup.altanalaw.com\/wp-content\/uploads\/2018\/04\/JNS-VG-300x148.jpg\"},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/backup.altanalaw.com\/#website\",\"url\":\"https:\/\/backup.altanalaw.com\/\",\"name\":\"Altana\",\"description\":\"Soci\u00e9t\u00e9 d&#039;avocats \u00e0 la Cour de Paris\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/backup.altanalaw.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ja\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/backup.altanalaw.com\/#\/schema\/person\/4bdb47072f79b38f30b44735a4377af6\",\"name\":\"Altana Communication\",\"url\":\"https:\/\/backup.altanalaw.com\/ja\/author\/altanacomm\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"[:fr]Altana conseille les actionnaires de Biofides et A.R.C. Pharma dans le cadre de leur cession au groupe Pharmalex[:en]Altana advises the shareholders of Biofides et A.R.C. Pharma in their acquisition by the Pharmalex group.[:] - Altana","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"ja_JP","og_type":"article","og_title":"[:fr]Altana conseille les actionnaires de Biofides et A.R.C. Pharma dans le cadre de leur cession au groupe Pharmalex[:en]Altana advises the shareholders of Biofides et A.R.C. Pharma in their acquisition by the Pharmalex group.[:] - Altana","og_description":"\u7533\u3057\u8a33\u3042\u308a\u307e\u305b\u3093\u3001\u3053\u306e\u30b3\u30f3\u30c6\u30f3\u30c4\u306f\u305f\u3060\u4eca\u3000Fran\u00e7ais\u3068 English\u3000\u306e\u307f\u3067\u3059\u3002 For the sake of viewer convenience, the content is shown below in [&hellip;]","og_url":"https:\/\/backup.altanalaw.com\/en\/medias\/altana-conseille-les-actionnaires-de-biofides-et-a-r-c-pharma-dans-le-cadre-de-leur-cession-au-groupe-pharmalex","og_site_name":"Altana","article_published_time":"2018-04-24T15:17:38+00:00","article_modified_time":"2018-11-23T09:26:15+00:00","og_image":[{"url":"http:\/\/backup.altanalaw.com\/wp-content\/uploads\/2018\/04\/JNS-VG-300x148.jpg"}],"author":"Altana Communication","twitter_card":"summary_large_image","twitter_misc":{"\u57f7\u7b46\u8005":"Altana Communication","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"3\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/backup.altanalaw.com\/en\/medias\/altana-conseille-les-actionnaires-de-biofides-et-a-r-c-pharma-dans-le-cadre-de-leur-cession-au-groupe-pharmalex","url":"https:\/\/backup.altanalaw.com\/en\/medias\/altana-conseille-les-actionnaires-de-biofides-et-a-r-c-pharma-dans-le-cadre-de-leur-cession-au-groupe-pharmalex","name":"[:fr]Altana conseille les actionnaires de Biofides et A.R.C. Pharma dans le cadre de leur cession au groupe Pharmalex[:en]Altana advises the shareholders of Biofides et A.R.C. Pharma in their acquisition by the Pharmalex group.[:] - Altana","isPartOf":{"@id":"https:\/\/backup.altanalaw.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/backup.altanalaw.com\/en\/medias\/altana-conseille-les-actionnaires-de-biofides-et-a-r-c-pharma-dans-le-cadre-de-leur-cession-au-groupe-pharmalex#primaryimage"},"image":{"@id":"https:\/\/backup.altanalaw.com\/en\/medias\/altana-conseille-les-actionnaires-de-biofides-et-a-r-c-pharma-dans-le-cadre-de-leur-cession-au-groupe-pharmalex#primaryimage"},"thumbnailUrl":"http:\/\/backup.altanalaw.com\/wp-content\/uploads\/2018\/04\/JNS-VG-300x148.jpg","datePublished":"2018-04-24T15:17:38+00:00","dateModified":"2018-11-23T09:26:15+00:00","author":{"@id":"https:\/\/backup.altanalaw.com\/#\/schema\/person\/4bdb47072f79b38f30b44735a4377af6"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/backup.altanalaw.com\/en\/medias\/altana-conseille-les-actionnaires-de-biofides-et-a-r-c-pharma-dans-le-cadre-de-leur-cession-au-groupe-pharmalex"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/backup.altanalaw.com\/en\/medias\/altana-conseille-les-actionnaires-de-biofides-et-a-r-c-pharma-dans-le-cadre-de-leur-cession-au-groupe-pharmalex#primaryimage","url":"http:\/\/backup.altanalaw.com\/wp-content\/uploads\/2018\/04\/JNS-VG-300x148.jpg","contentUrl":"http:\/\/backup.altanalaw.com\/wp-content\/uploads\/2018\/04\/JNS-VG-300x148.jpg"},{"@type":"WebSite","@id":"https:\/\/backup.altanalaw.com\/#website","url":"https:\/\/backup.altanalaw.com\/","name":"Altana","description":"Soci\u00e9t\u00e9 d&#039;avocats \u00e0 la Cour de Paris","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/backup.altanalaw.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ja"},{"@type":"Person","@id":"https:\/\/backup.altanalaw.com\/#\/schema\/person\/4bdb47072f79b38f30b44735a4377af6","name":"Altana Communication","url":"https:\/\/backup.altanalaw.com\/ja\/author\/altanacomm"}]}},"_links":{"self":[{"href":"https:\/\/backup.altanalaw.com\/ja\/wp-json\/wp\/v2\/posts\/5977"}],"collection":[{"href":"https:\/\/backup.altanalaw.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/backup.altanalaw.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/backup.altanalaw.com\/ja\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/backup.altanalaw.com\/ja\/wp-json\/wp\/v2\/comments?post=5977"}],"version-history":[{"count":5,"href":"https:\/\/backup.altanalaw.com\/ja\/wp-json\/wp\/v2\/posts\/5977\/revisions"}],"predecessor-version":[{"id":6076,"href":"https:\/\/backup.altanalaw.com\/ja\/wp-json\/wp\/v2\/posts\/5977\/revisions\/6076"}],"wp:attachment":[{"href":"https:\/\/backup.altanalaw.com\/ja\/wp-json\/wp\/v2\/media?parent=5977"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/backup.altanalaw.com\/ja\/wp-json\/wp\/v2\/categories?post=5977"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/backup.altanalaw.com\/ja\/wp-json\/wp\/v2\/tags?post=5977"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}